Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline
Sanofi will acquire Vigil Neuroscience, a clinical-stage biotech company in a $470 million deal, the companies said on Thursday, as the French dr-gmaker seeks to boost its neurological pipeline through an Alzheimer's dr-g.
https://www.reuters.com/markets/deals/sanofi-acquire-vigil-neuroscience-470-million-deal-2025-05-21/